Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Benzodiazepine use is widespread in older people, although its benefit is uncertain. AIM: To investigate the long-term effect of benzodiazepine use upon dementia risk. METHODS: A prospective cohort of men seen on five occasions over 22 years with full medication histories, repeat measures of cognitive function and a clinical diagnosis of dementia. RESULTS: Of 1134 men with complete data, 103 (9.1%) had been taking benzodiazepines regularly at one or more phases. These men showed a marked increased incidence of dementia (OR=3.50, 95% CI 1.57 to 7.79, p=0.002), which persisted despite adjustment for psychological distress and other covariates. Men exposed in earlier phases showed a greater association than more recent exposure, counter to what one would expect if this was due to reverse causation, though we failed to demonstrate a dose-response effect with drug duration. CONCLUSION: The taking of benzodiazepines is associated with an increased risk of dementia.

Original publication

DOI

10.1136/jech-2011-200314

Type

Journal article

Journal

J Epidemiol Community Health

Publication Date

10/2012

Volume

66

Pages

869 - 873

Keywords

Aged, Aged, 80 and over, Aging, Benzodiazepines, Cognition, Confidence Intervals, Dementia, Follow-Up Studies, Humans, Incidence, Logistic Models, Male, Middle Aged, Odds Ratio, Prospective Studies, Risk Factors, Time Factors, Wales